Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$554M |
| 2 |
Broadcom
AVGO
|
+$378M |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$324M |
| 4 |
Warner Bros
WBD
|
+$321M |
| 5 |
iShares National Muni Bond ETF
MUB
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$454M |
| 2 |
iShares MBS ETF
MBB
|
+$441M |
| 3 |
AT&T
T
|
+$266M |
| 4 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$198M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.98% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 12.8% |
| 4 | Consumer Discretionary | 9.34% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Ocular Therapeutix
OCUL
$1.79B
| $806K | ﹤0.01% |
200,369
-698
| -0.3% | -$2.64K |
|
2877
Civista Bancshares
CIVB
$604M
| $804K | ﹤0.01% |
37,804
-968
| -2% | -$21K |
|
2878
Primis Financial Corp
FRST
$399M
| $804K | ﹤0.01% |
58,971
-5,629
| -9% | -$75.5K |
|
|
RBOT
2879
DELISTED
Vicarious Surgical
RBOT
| $804K | ﹤0.01% |
9,112
+3,184
| +54% | +$389K |
|
|
EBTC
2880
DELISTED
Enterprise Bancorp
EBTC
| $803K | ﹤0.01% |
24,915
-80
| -0.3% | -$2.73K |
|
|
GNTY
2881
DELISTED
Guaranty Bancshares
GNTY
| $799K | ﹤0.01% |
22,025
+745
| +4% | +$26.4K |
|
2882
Century Therapeutics
IPSC
$364M
| $796K | ﹤0.01% |
94,731
+3,549
| +4% | +$34.8K |
|
2883
MINISO
MNSO
$3.88B
| $796K | ﹤0.01% |
101,399
+2,250
| +2% | +$15.4K |
|
|
IRNT
2884
DELISTED
IronNet, Inc.
IRNT
| $791K | ﹤0.01% |
357,621
+189,276
| +112% | +$534K |
|
2885
Viridian Therapeutics
VRDN
$2.09B
| $790K | ﹤0.01% |
+68,246
| New | +$917K |
|
|
BLUE
2886
DELISTED
bluebird bio
BLUE
| $787K | ﹤0.01% |
9,502
+405
| +4% | +$31.4K |
|
2887
Five Star Bancorp
FSBC
$1.01B
| $786K | ﹤0.01% |
29,746
-336
| -1% | -$8.89K |
|
2888
Arbutus Biopharma
ABUS
$857M
| $781K | ﹤0.01% |
287,954
+48,241
| +20% | +$123K |
|
|
SMMF
2889
DELISTED
Summit Financial Group, Inc.
SMMF
| $775K | ﹤0.01% |
27,896
-358
| -1% | -$9.51K |
|
2890
Pliant Therapeutics
PLRX
$64.4M
| $774K | ﹤0.01% |
96,542
-70,235
| -42% | -$450K |
|
2891
Omeros
OMER
$857M
| $773K | ﹤0.01% |
280,866
-176,026
| -39% | -$597K |
|
|
NEUE
2892
DELISTED
NeueHealth
NEUE
| $773K | ﹤0.01% |
5,302
-1,911
| -26% | -$278K |
|
2893
NWPX Infrastructure Inc
NWPX
$1.19B
| $772K | ﹤0.01% |
25,758
-293
| -1% | -$8.7K |
|
2894
Allient
ALNT
$1.49B
| $771K | ﹤0.01% |
33,753
+1,571
| +5% | +$38.6K |
|
2895
iShares Russell Mid-Cap ETF
IWR
$56B
| $770K | ﹤0.01% |
11,900
+1,400
| +13% | +$99.7K |
|
|
GTHX
2896
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $768K | ﹤0.01% |
155,315
-111,030
| -42% | -$615K |
|
2897
Daily Journal
DJCO
$809M
| $763K | ﹤0.01% |
2,946
-77
| -3% | -$20.7K |
|
2898
Cadre Holdings
CDRE
$1.32B
| $762K | ﹤0.01% |
38,690
+21,682
| +127% | +$511K |
|
2899
Amalgamated Financial
AMAL
$1.47B
| $759K | ﹤0.01% |
38,365
+19
| +0% | +$367 |
|
2900
Sierra Bancorp
BSRR
$528M
| $759K | ﹤0.01% |
34,885
-2,552
| -7% | -$57K |
|
Similar funds
Charles Schwab's Q2 2022 Portfolio in Review
As of Q2 2022, Charles Schwab held 3,742 positions worth $287B, down 14% from $333B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2022 filing shows 162 new, 2,018 increased, 1,243 reduced and 206 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M. The largest sale was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $454M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2022 buy was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M.
- Charles Schwab added most to Cisco in Q2 2022, an estimated $554M increase.
- Charles Schwab's biggest Q2 2022 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $454M.
- Charles Schwab fully exited Cerner Corp in Q2 2022, selling an estimated $140M.
- Charles Schwab's ten largest holdings make up 17% of its $287B portfolio in Q2 2022.
- Charles Schwab opened 162 new positions and closed 206 in Q2 2022.
- Charles Schwab's portfolio value fell 14% quarter-over-quarter to $287B.
Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.